Literature DB >> 8088866

Studies on the lymphocytosis induced by pertussis toxin.

H H Mu1, M A Cooley, W A Sewell.   

Abstract

Pertussis toxin (PT), from Bordetella pertussis, causes lymphocytosis and increased IL-4 and IgE secretion. The lymphocytosis is associated with impaired entry of lymphocytes into lymph nodes. The dose response of PT on IL-4 secretion was found to be similar to those for lymphocytosis and IgE production. These findings are consistent with the possibility that increased IL-4 production by PT may be related to its effect on lymphocyte circulation. The possibility that PT may selectively influence the entry into lymph nodes of subsets identified with CD45RB, CD4 or CD8 was tested by assessing the phenotype of lymph node cells. PT had no significant effect on the proportion of cells with these markers, either in unimmunized or in immunized mice. These findings indicate that PT does not selectively impair entry of these lymphocyte subsets into lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088866     DOI: 10.1038/icb.1994.40

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  3 in total

Review 1.  Pertussis leukocytosis: mechanisms, clinical relevance and treatment.

Authors:  Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2016-09-07       Impact factor: 3.166

Review 2.  Bordetella pertussis pathogenesis: current and future challenges.

Authors:  Jeffrey A Melvin; Erich V Scheller; Jeff F Miller; Peggy A Cotter
Journal:  Nat Rev Microbiol       Date:  2014-03-10       Impact factor: 60.633

3.  A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough.

Authors:  Annalee W Nguyen; Ellen K Wagner; Joshua R Laber; Laura L Goodfield; William E Smallridge; Eric T Harvill; James F Papin; Roman F Wolf; Eduardo A Padlan; Andy Bristol; Michael Kaleko; Jennifer A Maynard
Journal:  Sci Transl Med       Date:  2015-12-02       Impact factor: 17.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.